China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Gut Microbiota and Its Metabolites Contribute to Sepsis-Induced Myocardial Injury via the GPR15/RAP1 Signaling Axis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129439
Registration Time: 2026/08/04
Type: Observational study
Primary Sponsor: Zhangzhou Affiliated Hospital of Fujian Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=319123
Published by HT Digital Content Services with permission from Health Daily Digest....